Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDP.L Regulatory News (IDP)

  • There is currently no data for IDP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

18 Nov 2020 07:00

RNS Number : 6500F
InnovaDerma PLC
18 November 2020
 

 LEI: 213800WRAP6W8VDL6B38

InnovaDerma PLC

("InnovaDerma" or the "Group")

Appointment of Chief Executive Officer

InnovaDerma (LSE: IDP), a leading developer of beauty, personal care and life science products, is pleased to announce that Blake Hughes has been appointed Chief Executive Officer ("CEO") of the Group with immediate effect. He will be based in the UK.

Blake has spent his career in the beauty and personal care sectors and brings with him extensive marketing and digital analytics experience. Most recently, he held the roles of CEO and Chief Marketing Officer of Philip Kingsley, the award-winning premium hair care range. During his tenure at Philip Kingsley, he defined its brand strategy, transformed its eCommerce platform, created a structured product innovation pipeline and step changed international distribution.

Prior to joining Philip Kingsley, Blake was Managing Director, Europe and Africa, of Murad, the prestigious skin care brand. He successfully transformed the business model of this former UK distribution only joint venture into a profitable regional headquarter that managed the distribution of Murad into Europe, Middle East and Africa.

Blake has also worked in a variety of brand and marketing roles for blue chip companies including Procter & Gamble, Elizabeth Arden and Marks & Spencer. He holds a Masters in Chemistry from Oxford University.

 

Joe Bayer will step down as Interim CEO with immediate effect. He will remain as Executive Chairman to support Blake and ensure a smooth handover of the CEO function. Joe intends to step back to Non-executive Chairman after the transition has been completed.

 

Executive Chairman, Joe Bayer, said:

"After an extensive search process, I am very pleased to announce that Blake Hughes has agreed to assume the role of CEO at InnovaDerma. His impressive leadership record and proven ability to generate topline revenue growth whilst improving margins at both blue chip companies and smaller businesses, together with his sector knowledge of the personal care and beauty business, makes him the ideal candidate to lead InnovaDerma. I look forward to working with him as we continue to expand our digital platform and retail network globally."

 

Blake Hughes said:

"I am really excited to be joining InnovaDerma as its new CEO, it's a business with an impressive stable of strong, digitally focused brands which I have long admired. 

 

"I passionately believe in the company's potential to deliver strong financial growth by continuing to build a sustainable digital competitive advantage, drive brand innovation and create exceptional brand experiences for more consumers around the world. InnovaDerma has significant expansion potential and I am proud to join them at this exciting stage of their development."

 

There is no further information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to Blake Hughes' appointment.

 

 

Further enquiries

 

InnovaDerma

Joe Bayer

 

 

+61 417 870 743

 

finnCap Ltd

Geoff Nash/Kate Bannatyne

Alice Lane - Corporate Broking

 

+44 (0)207 220 0500

www.finncap.com

TB Cardew

Shan Shan Willenbrock/Tom Allison

Olivia Rosser

 

+ 44 (0)20 7930 0777

innovaDerma@tbcardew.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFFWEFWESSEDF
Date   Source Headline
15th Oct 20202:00 pmRNSPrice Monitoring Extension
30th Sep 20207:00 amRNSFinal Results
28th Sep 20207:00 amRNSUS distributor appointed and Nuthing launch in AUS
18th Sep 20207:00 amRNSNotice of Results and Presentation
1st Sep 20209:37 amRNSHolding(s) in Company
12th Aug 202010:58 amRNSHolding(s) in Company
5th Aug 20209:15 amRNSDirectorate Change
31st Jul 202010:22 amRNSHolding(s) in Company
13th Jul 20209:40 amRNSHolding(s) in Company
10th Jul 20207:00 amRNSTrading Statement
1st Jul 202010:10 amRNSHolding(s) in Company
12th Jun 20205:57 pmRNSHolding(s) in Company
26th May 20207:00 amRNSTrading Statement
13th May 20204:42 pmRNSHolding(s) in Company
7th May 202010:52 amRNSDirector/PDMR Shareholding
6th May 202010:05 amRNSHolding(s) in Company
4th May 202011:09 amRNSHolding(s) in Company
30th Apr 202011:05 amRNSSecond Price Monitoring Extn
30th Apr 202011:00 amRNSPrice Monitoring Extension
6th Apr 20202:05 pmRNSSecond Price Monitoring Extn
6th Apr 20202:00 pmRNSPrice Monitoring Extension
6th Apr 20207:00 amRNSCOVID-19 Update
23rd Mar 20207:00 amRNSDirector/PDMR Shareholding
18th Mar 20201:56 pmRNSDirector/PDMR Shareholding
17th Mar 20201:52 pmRNSHolding(s) in Company
16th Mar 202012:54 pmRNSDirector/PDMR Shareholding
12th Mar 20202:37 pmRNSDirector/PDMR Shareholding
12th Mar 202011:06 amRNSSecond Price Monitoring Extn
12th Mar 202011:00 amRNSPrice Monitoring Extension
3rd Mar 202010:47 amRNSDirector/PDMR Shareholding
25th Feb 202011:52 amRNSHalf-year Report- Replacement
25th Feb 20207:00 amRNSHalf-year Report
24th Feb 20207:00 amRNSInnovaDerma launches new brand "Nuthing"
3rd Feb 20207:00 amRNSNotice of Results
23rd Jan 20208:48 amRNSGrant of Options/PDMR Dealing
9th Jan 20207:00 amRNSTrading Statement
5th Dec 20197:00 amRNSDTC channel delivers best Black Friday weekend
29th Nov 20192:26 pmRNSDirector/PDMR Shareholding
28th Nov 20193:21 pmRNSDirector/PDMR Shareholding
20th Nov 20197:00 amRNSLaunch of new Skinny Tan 'Choc' range in Superdrug
13th Nov 201912:39 pmRNSDirector/PDMR Shareholding
8th Nov 20193:40 pmRNSDirector/PDMR Shareholding
8th Nov 20193:22 pmRNSDirector/PDMR Shareholding
7th Nov 20192:33 pmRNSHolding(s) in Company
7th Nov 20191:55 pmRNSHolding(s) in Company
7th Nov 20191:53 pmRNSDirector/PDMR Shareholding
7th Nov 20191:47 pmRNSDirectorate Change
6th Nov 201911:01 amRNSResult of AGM
6th Nov 20197:00 amRNSAGM Statement
31st Oct 20197:00 amRNSLaunch of new category in Superdrug

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.